Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Dichloromethane | HCID 6344 | — |
| Reactant | 2-[4-(3-Aminopropyl)piperazin-1-yl]ethan-1-ol | HCID 255283 | — |
| Reactant | 4-(9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[5,4-b][1,4]diazepin-2-ylamino)-3-methoxybenzoic acid | HCID 25252905 | — |
| Reactant | HCID 178484293 | HCID 178484293 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | Triethylamine | HCID 8471 | — |
| Product | HCID 58015154 | HCID 58015154 | 8% |
Reaction Steps
To a mixture of 0.051 g (0.11 mmole) of 4-(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-3-methoxy-benzoic acid (I-22), 0.0494 g (0.13 mmole) of 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium-3-oxide hexafluorophosphate, 0.6 mL of dichloromethane, 0.6 mL of dimethylformamide, 0.12 mL of triethylamine was added followed by 0.0235 g (0.13 mmole) of 2-[4-(3-amino-propyl)-piperazin-1-yl]-ethanol. After stirring 1.5 hours, the mixture was concentrated under reduced pressure. The residue was purified by silica gel chromatography, eluting with acetonitrile-water (gradient, 5:95-0:100) to give 0.0054 g of 4-(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-N-{3-[4-(2-hydroxy-ethyl)-piperazin-1-yl]-propyl}-3-methoxy-benzamide (I-96).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08003785B2 |
|---|
| Source dataset | uspto-grants-2011_08 |
|---|
| ORD ID | ord-368d245e33a343b98b332e9c8919799e |
|---|
| Source note | uspto-grants-2011_08 |
|---|